Identify and pursue strategic opportunities for IHC and NGS based diagnostic programs for targeted therapies and immuno-oncology agents
Serve as the strategic thought partner to senior executives and R D leadership at biopharma companies, fostering trust, strategic, and scientific alignment
Serve as the BD lead managing diagnostic partnerships from early-stage evaluation through deal closing
Define partnership value propositions by integrating our scientific strengths with the commercial needs of biopharma customers
Oversee implementation of joint go-to-market plans, ensuring alignment on launch timing, geographies, messaging, and field deployment
Help strengthen external materials that clearly communicate the value of our diagnostic offerings to clinicians, KOLs, and payers
Lead diagnostic partnerships and act as a key escalation point, ensuring consistent communication between internal stakeholders and partner organizations

MS or PhD in molecular biology, genomics, oncology, or related field
A minimum of 8 years professional work experience
5+ years of experience in the molecular diagnostics, biopharma, or precision medicine sectors, with a clear focus on diagnostics and oncology
Proven business development track record (e.g., deal sheet) leading diligences, and complex organization-wide efforts to deliver partnerships with Biopharma
Transactions knowledge (e.g., contracting, deal sheets, multi-tier / multi-constituent decision making, etc.)
Experience as the external face of the organization, leading and participating in BD partnering events (e.g., JPM, BIO) and oncology conferences
Strong grasp of oncology therapeutic development, biomarker strategy, and regulatory pathways for Dx in global markets
Excellent communication, negotiation, and program leadership skills

Director – Diagnostics Partnering

Key skills